Edwards Lifesciences Corporation v. Meril Life Sciences Pvt. Ltd.

Good Law
United States District Court, Northern District of CaliforniaNovember 18, 20214:19-cv-06593California3,892 words

Opinion

Trial Court Opinion

I. BACKGROUND

23 Because this case has been actively litigated, the Court limits its review of the factual and 24 procedural background to that relevant to the pending motions. Defendants are an India-based, 25 global medical device company that created a “Myval” branded transcatheter heart valve. Dkt. 26 27 No. 98 at 1. Plaintiffs supply medical devices for the treatment of heart disease, including artificial heart valves. Id. at 2. Among their best-known products are their “SAPIEN®” transcatheter prosthetic heart valves. Id. On October 14, 2019, Plaintiffs brought the current lawsuit against Defendants alleging patent infringement, trademark infringement, unfair competition, and false advertising claims relating to the parties’ transcatheter heart valves. Dkt. No. 1 at 25-31. On April 6, 2020, Plaintiffs filed an amended complaint with claims for: (1) Statutory and Common Law Trademark Infringement in violation of 15 U.S.C. § 1114 and the common law; (2) Unfair Competition in violation of 15 U.S.C. § 1125(a); and (3) Unfair Competition and False Advertising in violation of §§ 17200 and 17500 of the California Business and…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.